FDA Inspection 1020745 — Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy
The FDA completed an inspection of Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy on August 1, 2017 in Seattle, WA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 1, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Seattle, WA (United States)